Patients with primary care appointments in the morning were more likely to have orders for and receive recommended breast and colorectal cancer screenings.
The time of your primary care appointment may influence whether you are ordered for cancer screening, according to a new study, which found that physicians are more likely to order cancer screening in the morning.
Underuse of cancer screening tests is common, with the CDC estimating that among patients who meet guideline recommendations, approximately 37% of adults have not been screened for colorectal cancer and 28% of women have not been screened for breast cancer. As a result, identifying target areas to improve screening is crucial.
Examining screening test order rates from 33 primary care practices in Pennsylvania and New Jersey between September 1, 2014, and August 31, 2016, the researchers found that rates were highest early in the morning and dipped toward the end of morning and afternoon shifts.
Among more than 19,000 patients eligible for breast cancer screening, test order rates were 63.7% at 8:00 am, 48.7% at 11:00 am, 56.2% at noon, and 47.8% at 5:00 pm. Similarly, for the nearly 33,500 patients eligible for colorectal cancer screening, test order rates dropped from 36.5% at 8:00 am to 23.8% at 11:00 am and increased to 26.3% at noon before dropping again to 23.4% at 5:00 pm.
The time of day might influence this decision making in several ways, according to the researchers. For example, as each shift progresses, clinicians may fall behind schedule, leading to shorter interactions with the patient at the end of the morning and afternoon shifts and causing cancer screening discussions to be pushed to a future visit.
“As the overall clinic day progresses, clinicians may face decision fatigue, defined as the depletion of self-control and active initiative that results from the cumulative burden of decision making,” added the researchers.
One year of follow-up revealed that patient completion rates of screening tests followed a pattern similar to that seen with screening test order rates. Among patients with orders for breast cancer screening, completion rates were 33.2% for those who were ordered during an 8:00 am appointment, 23.8% at 11:00 am, 26.3% at noon, and 17.8% at 5:00 pm.
Among patients ordered for colorectal cancer screening, completion rates were 28% at 8:00 am, 23.6% at 11:00 am, 25.6% at noon, and 17.8% at 5:00 pm.
“This indicates that decisions made during a single primary care provider visit may have a lasting effect on patient behaviors,” wrote the researchers. “Clinicians may decide to defer discussion of cancer screening or other guideline-recommended care to future visits, and these findings indicate that this could potentially result in suboptimal care.”
They did note that screening tests must be completed outside of the primary care provider, suggesting that improving completion rates may require interventions outside of the primary care visit.
Reference
Hsiang E, Mehta S, Small D, et al. Association of primary care clinic appointment time with clinician ordering and patient completion of breast and colorectal cancer screening [published online May 10, 2019]. JAMA Netw Open. doi: 10.1001/jamanetworkopen.2019.3403.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More